Utilizing Intra- and Peritumoral Radiomics to Assess Ambiguous HER2 Status in Breast Cancer via Contrast-Enhanced Mammography - Scorecard - MDSpire

Utilizing Intra- and Peritumoral Radiomics to Assess Ambiguous HER2 Status in Breast Cancer via Contrast-Enhanced Mammography

  • By

  • Cong Xu

  • Juan Qiu

  • Shijie Zhang

  • Yuqian Chen

  • Xiaodong Wang

  • Haicheng Zhang

  • Qi Wang

  • Tongpeng Chu

  • Ziyin Li

  • Peng Lu

  • Haizhu Xie

  • Heng Ma

  • Nina Qu

  • Ning Mao

  • Jing Liu

  • Runpeng Chen

  • Jing Gao

  • April 29, 2026

  • 0 min

Share

Clinical Scorecard: Utilizing Intra- and Peritumoral Radiomics to Assess Ambiguous HER2 Status in Breast Cancer via Contrast-Enhanced Mammography

At a Glance

CategoryDetail
ConditionAmbiguous HER2 Status in Breast Cancer
Key MechanismsIntra- and peritumoral radiomics features from contrast-enhanced mammography (CEM)
Target PopulationBreast cancer patients with equivocal HER2 (IHC 2+) status
Care SettingClinical practice utilizing contrast-enhanced mammography

Key Highlights

  • Study involved 131 breast cancer patients with equivocal HER2 (IHC 2+) status.
  • Nomogram achieved an AUC of 0.893 in the internal test cohort.
  • Incorporated intratumoral and peritumoral radiomics signatures for predictive modeling.
  • CEM provides a non-invasive method to predict HER2 status.
  • Potential to reduce reliance on FISH testing for HER2 status confirmation.

Guideline-Based Recommendations

Diagnosis

  • Utilize contrast-enhanced mammography for assessing HER2 status.

Management

  • Incorporate radiomics features into clinical decision-making for HER2-positive breast cancer treatment.

Monitoring & Follow-up

  • Monitor predictive performance of the nomogram through calibration curves and decision curve analysis.

Risks

  • Consider the time and cost implications of additional FISH testing for equivocal HER2 status.

Patient & Prescribing Data

Breast cancer patients with equivocal HER2 (IHC 2+) status.

Timely identification of HER2 status is crucial for guiding treatment.

Clinical Best Practices

  • Employ a nomogram that integrates radiomics and clinical factors for preoperative HER2 status prediction.
  • Utilize CEM as a standard imaging technique in clinical practice.

References

Original Source(s)

Related Content